Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas.

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• The Nottingham Prognostic Index (NPI) is a valuable tool for stratifying invasive breast carcinoma patients.
• NPI integrates metastatic potential, growth rate, and genetic instability, offering advantages over other clinicopathologic features.
• NPI as a continuous variable provides a sensitive method for modeling clinical aggressiveness.

Purpose of the Study:

• To develop a novel gene expression profiling approach for invasive breast carcinoma.
• To identify gene expression patterns correlated with the Nottingham Prognostic Index (NPI).
• To explore the potential of these gene expression profiles in distinguishing patient prognostic groups.

Main Methods:

• Gene expression profiling of 26 invasive breast carcinoma tumors using cDNA microarrays (23,343 genetic elements).
• Correlation analysis between gene expression and NPI using Spearman rank correlation and null distribution analysis.
• Validation of differential gene expression using immunohistochemistry (IHC).

Main Results:

• Identified 84 genes and expressed sequence tags with expression patterns correlating to NPI.
• Two of three evaluated genes showed differential expression by IHC.
• The 84 identified genetic elements include known cancer-related genes, genes at cytogenetically altered chromosomal sites, and novel genes.
• Expression patterns of these 84 elements can distinguish between high and low NPI patient samples.

Conclusions:

• Gene expression profiles reflect distinct prognostic groups in breast carcinoma.
• A limited set of genes can characterize the prognostic status of breast cancer patients.
• This approach offers potential for improved breast cancer patient stratification and prognosis.